Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBIT (2016 - 2025)

Re (RMAX) has disclosed EBIT for 14 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 118.17% to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.0 million through Dec 2025, up 17.08% year-over-year, with the annual reading at $47.0 million for FY2025, 17.08% up from the prior year.
  • EBIT for Q4 2025 was $9.3 million at Re, down from $18.3 million in the prior quarter.
  • The five-year high for EBIT was $18.3 million in Q3 2025, with the low at -$37.6 million in Q3 2021.
  • Average EBIT over 5 years is $5.2 million, with a median of $8.0 million recorded in 2022.
  • The sharpest move saw EBIT plummeted 501.11% in 2023, then skyrocketed 172.44% in 2024.
  • Over 5 years, EBIT stood at $10.4 million in 2021, then dropped by 18.88% to $8.5 million in 2022, then plummeted by 214.58% to -$9.7 million in 2023, then soared by 144.03% to $4.3 million in 2024, then soared by 118.17% to $9.3 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at $9.3 million, $18.3 million, and $14.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.